ctDNA Tracks Relapse Risk in Breast Cancer - Poll - MDSpire

ctDNA Tracks Relapse Risk in Breast Cancer

Personalized liquid biopsy testing identified molecular residual disease months before clinical recurrence

  • June 9, 2026

  • 2 min

Share

Original Source(s)

ctDNA Tracks Relapse Risk in Breast Cancer

  • June 9, 2026

Related Content

Case Report: Synaptophysin-positive SMARCA4-deficient undifferentiated thoracic tumour: a diagnostic pitfall with therapeutic implications

Target receptor expression dictates the selective intra-tumoral targeting of CD8+ T cells by eciskafusp alfa in matched PBMCs and TILs from CPI-naïve patients

Micronodular PEComa of the appendix: a case report